Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
Nurix Therapeutics (NASDAQ:NRIX) Now Covered by Analysts at BTIG Research
Research analysts at BTIG Research initiated coverage on shares of Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) in a note...
RB Capital Management LLC Acquires New Position in Fidelity National Information Services, Inc. (NYSE:FIS)
RB Capital Management LLC purchased a new stake in shares of Fidelity National Information Services, Inc. (NYSE:FIS – Free Report)...
RB Capital Management LLC Acquires 100 Shares of Agilent Technologies, Inc. (NYSE:A)
RB Capital Management LLC raised its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 6.3% during...
Savoie Capital LLC Purchases New Stake in Lululemon Athletica Inc. (NASDAQ:LULU)
Savoie Capital LLC acquired a new position in Lululemon Athletica Inc. (NASDAQ:LULU – Free Report) during the 3rd quarter, according...
Coldstream Capital Management Inc. Buys 171 Shares of Aflac Incorporated (NYSE:AFL)
Coldstream Capital Management Inc. boosted its stake in Aflac Incorporated (NYSE:AFL – Free Report) by 0.3% in the third quarter,...
Zoetis (NYSE:ZTS) Now Covered by UBS Group
Equities research analysts at UBS Group initiated coverage on shares of Zoetis (NYSE:ZTS – Get Free Report) in a research...